Resection of stage III non-small cell lu
β
Valerie W. Rusch
π
Article
π
1995
π
Springer
π
English
β 779 KB
Approximately 25%-30% of all patients with non-small cell lung cancer (NSCLC) present with stage III tumors. Except for specific subsets, these tumors are not usually amenable to complete surgical resection and are associated with a 5-year survival of 10% or less. Because patients with stage III NSC